dfern.eth.xyz
Mainly on Farcaster! (https://warpcast.com/dfern.eth)
Software Engineer interested in chip design, compchem/bio, crypto & DWeb tech.
295 posts
436 followers
743 following
Regular Contributor
Active Commenter
comment in response to
post
did:ethr is actually mentioned in the ATProto monorepo as an example of a valid (but not supported) did method, so it's certainly on their radar
comment in response to
post
I'm looking at using did:ethr, but I think I prefer some of the did:eth725 design if it could be brought forward to modern standards using CAIP-10/EIP-155 chainID formatting.
comment in response to
post
(FYI I think he uses @hananiarichard.bsky.social)
comment in response to
post
That's a squatted account
comment in response to
post
Try Recaster, it's mainly a linear/temporal feed, similar to BSky.
comment in response to
post
Using tools is what our opposable thumbs are for
comment in response to
post
yes bsky.app/profile/jare...
comment in response to
post
a broken clock is right twice a day 😏
comment in response to
post
I agree with the broader spirit of your post, but you mentioned Jesuits, which some may take to mean there's some relationship between this rube and Roman Catholicism. Understandably confusing.
comment in response to
post
He was in the Anglican Catholic church not Roman Catholic.
comment in response to
post
He was never charged with murder.
comment in response to
post
correct
comment in response to
post
where was Ross charged with murder?
comment in response to
post
It looks like the account was deleted, so it will eventually drop out of the index. warpcast.com/dfern.eth/0x...
comment in response to
post
You should be able to initiate account recovery in the app (perhaps when you log out), or from this link: warpcast.com/~/recovery-i...
comment in response to
post
They recently fixed a bug related to account recovery, have you tried to recover that account recently? The recommendation is to try again: warpcast.com/dwr.eth/0x0e...
comment in response to
post
It's $3 as an anti-spam measure to signup, but I'm happy to send over an invite code, it's also preferred b/c then you're bootstrapped with at least 1 follower, so algos know you're less likely to be a bot.
comment in response to
post
what issue are you having? might be able to help, or I can ping some people at Merkle if you need account recovery
comment in response to
post
They play in the San Francisco Bay Area, which is better than the New York Jets & NY Giants...which play in New Jersey
comment in response to
post
Make sure the bowl fill tube is clipped to the top of the overflow pipe. I had a repair guy that just put the fill tube into the pipe...which placed the end tip below the water level...causing a constant siphon (& refills).
comment in response to
post
I lost a good chunk of my 20s due to the pandemic, didn't want to get my parents sick or dead. I moved out when I accepted the argument that perma-renting (a la Ramit Sethi) was the financially responsible thing to do, and trying to 'save' for a house or FI/RE was pennywise, pound foolish.
comment in response to
post
A shame that open graph previews for FC don't work here, but to be fair, I don't think it works vice versa
comment in response to
post
Not my field, but I imagine it rhymes with Spruce Byneier
comment in response to
post
Bitters & Bottles is one of my favorite bottle shops.
comment in response to
post
My favorite is an nonalc Army & Navy. Something like: 2 oz Seedlip Garden 108, 1 oz lemon juice, 3/4 Orgeat syrup, 1 dash of Agnostura. Shake & strain into a coupe.
comment in response to
post
Presumably she means CCP leadership? There are no CEOs in China after the CCP disappeared Jack Ma
comment in response to
post
👋👍
comment in response to
post
I once heard the mitochondria is the powerhouse of the cell
comment in response to
post
holy smokes, don't the ppl developing cures deserve a little bit better than this? $BLUE
comment in response to
post
Not to bury the lede, but we don't even know who the insurance company is, shouldn't they get credit for taking the risk of approval with this experimental treatment?